Key facts
- This page summarizes Richard S. Eiswirth Jr.'s Form 4 filing for ALIMERA SCIENCES INC.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Oct 2023, 16:38.
Richard S. Eiswirth Jr. - 02 Oct 2023 Form 4 Insider Report for ALIMERA SCIENCES INC
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 02 Oct 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Oct 2023, 16:38:02 UTC
- Prior SEC filing
- 28 Mar 2023
- Next SEC filing
- 13 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard S Eiswirth, Jr.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard S. Eiswirth Jr. filed Form 4 for ALIMERA SCIENCES INC on 04 Oct 2023.
Change
- Previous filing in this sequence was filed on 28 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALIM
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +400,000
- Change %
- +124%
- Price
- $0.000000
- Shares after
- 722,518
- Date
- 02 Oct 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALIM
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +400,000
- Change %
- Price
- $0.000000
- Shares after
- 400,000
- Date
- 02 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 400,000
- Exercise price
- $2.99
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSUs vest in four equal annual installments beginning October 2, 2023, with the first annual installment vesting on October 2, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the grant date through the applicable anniversary thereof.
Footnote F2
The options shall vest and become exercisable in equal monthly installments over the next forty-eight (48) months of the Reporting Person's continuous service with the Issuer, with the final installment adjusted as necessary to avoid any fractional shares in any installment.